Insider Transactions Reported by 29 Insiders of Pacira BioSciences, Inc.

Symbol
PCRX on Nasdaq
Location
Brisbane, CA

Insiders trading volume in the past year

Pacira BioSciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Frank D. Lee Chief Executive Officer, Director $17,102,302 11 Feb 2026
David M. Stack CEO and Chairman, Director $16,210,466 14 Jun 2023
Jonathan Slonin Chief Medical Officer $5,872,202 -$95,396 -1.6% 11 Feb 2026
Kristen Williams Chief Administrative Officer $4,809,772 -$646,929 -12% 11 Feb 2026
Shawn Cross Chief Financial Officer $2,726,225 -$893,157 -25% 11 Feb 2026
Brendan Teehan Chief Commercial Officer $2,612,178 11 Feb 2026
Charles A. Reinhart III Chief Financial Officer $2,070,260 12 Jun 2024
Lauren Riker Senior Vice President, Finance $1,852,651 -$263,772 -12% 11 Feb 2026
Daryl Gaugler Chief Operating Officer $1,848,712 31 Dec 2024
Roy Winston Chief Medical Officer $1,678,091 02 Aug 2023
Charles Anthony Laranjeira Chief Technical Officer $1,575,374 14 Jun 2022
Donald C. Manning Chief Medical Officer $1,343,490 09 Jun 2021
Dennis McLoughlin Chief Customer Officer $1,219,680 06 Jun 2023
Mark A. Kronenfeld Director $1,200,553 11 Jun 2025
Gary W. Pace Director $1,020,762 06 Mar 2024
Ronald J. Ellis Jr. Chief Strategy Officer $989,088 06 Jun 2023
Max Reinhardt President, Rest of World $935,200 06 Jun 2023
Laura Brege Director $919,560 11 Jun 2025
Mark Froimson Director $842,216 11 Jun 2025
Christopher Christie Director $742,188 11 Jun 2025
Paul J. Hastings Director $684,947 12 Jun 2024
Michael J. Yang Director $660,272 11 Jun 2025
Yvonne Greenstreet Director $642,607 08 Jun 2022
Alethia Young Director $610,032 11 Jun 2025
John P. Longenecker PhD Director $602,336 03 Mar 2022
Marcelo Bigal Director $593,512 -$116,267 -16% 07 Aug 2025
Abraham Ceesay Director $569,610 -$64,005 -10% 04 Sep 2025
Anthony Molloy Chief Lgl & Compliance Officer $412,064 05 Jun 2023
Samit Hirawat Director 27 Jan 2026

Recent Insider Transactions by Companies or Individuals for Pacira BioSciences, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Shawn Cross PCRX Common Stock Award 87.3% 49,091 105,341 11 Feb 2026 Direct
Kristen Williams PCRX Common Stock Award 41.5% 54,546 185,849 11 Feb 2026 Direct
Brendan Teehan PCRX Common Stock Award 105.1% 51,714 100,934 11 Feb 2026 Direct
Lauren Riker PCRX Common Stock Award 36.8% 19,273 71,586 11 Feb 2026 Direct
Jonathan Slonin PCRX Common Stock Award 31.6% 54,546 226,901 11 Feb 2026 Direct
Frank D. Lee PCRX Common Stock Award 65.6% 261,818 660,831 11 Feb 2026 Direct
Lauren Riker PCRX Common Stock Sale -7.1% $83,240 $20.81 -4,000 52,313 02 Feb 2026 Direct
Kristen Williams PCRX Common Stock Sale -9.1% $269,703 $20.53 -13,137 131,303 02 Feb 2026 Direct
Lauren Riker PCRX Common Stock Tax liability -4.66% -2,751 56,313 30 Jan 2026 Direct
Jonathan Slonin PCRX Common Stock Tax liability -3.46% -6,168 172,355 30 Jan 2026 Direct
Brendan Teehan PCRX Common Stock Tax liability -9.53% -5,182 49,220 30 Jan 2026 Direct
Frank D. Lee PCRX Common Stock Tax liability -9.42% -41,488 399,013 30 Jan 2026 Direct
Kristen Williams PCRX Common Stock Tax liability -10.6% -17,134 144,440 30 Jan 2026 Direct
Samit Hirawat PCRX Stock Option (Right to Buy) Award 39,291 39,291 27 Jan 2026 Direct
Lauren Riker PCRX Common Stock Sale -2.34% $34,324 $24.24 -1,416 59,064 05 Jan 2026 Direct
Jonathan Slonin PCRX Common Stock Tax liability -0.21% -381 178,523 02 Jan 2026 Direct
Lauren Riker PCRX Common Stock Tax liability -0.26% -159 60,480 02 Jan 2026 Direct
Frank D. Lee PCRX Common Stock Tax liability -2.06% -9,272 440,501 02 Jan 2026 Direct
Brendan Teehan PCRX Common Stock Award 0.74% 402 54,402 31 Dec 2025 Direct
Shawn Cross PCRX Common Stock Sale -13.9% $228,875 $25.14 -9,104 56,250 10 Dec 2025 Direct
Shawn Cross PCRX Common Stock Options Exercise 16.2% 9,104 65,354 10 Dec 2025 Direct
Shawn Cross PCRX Stock Option (Right to Buy) Options Exercise -4.95% -9,104 175,000 10 Dec 2025 Direct
Shawn Cross PCRX Common Stock Sale -22% $397,877 $25.03 -15,896 56,250 09 Dec 2025 Direct
Shawn Cross PCRX Common Stock Options Exercise 28.3% 15,896 72,146 09 Dec 2025 Direct
Shawn Cross PCRX Stock Option (Right to Buy) Options Exercise -7.95% -15,896 184,104 09 Dec 2025 Direct
Jonathan Slonin PCRX Common Stock Sale -2.17% $95,396 $24.09 -3,960 178,367 17 Nov 2025 Direct
Shawn Cross PCRX Common Stock Sale -17.6% $266,405 $22.09 -12,060 56,250 10 Nov 2025 Direct
Shawn Cross PCRX Common Stock Tax liability -8.92% -6,690 68,310 31 Oct 2025 Direct
Abraham Ceesay PCRX Common Stock Sale -20.7% $64,005 $27.19 -2,354 9,039 04 Sep 2025 Direct
Marcelo Bigal PCRX Common Stock Sale -30.1% $116,267 $23.67 -4,912 11,393 07 Aug 2025 Direct
Jonathan Slonin PCRX Common Stock Tax liability -0.17% -315 182,327 01 Aug 2025 Direct
Mark A. Kronenfeld PCRX Common Stock Award 40.2% 9,999 34,901 11 Jun 2025 Direct
Mark A. Kronenfeld PCRX Stock Option (Right to Buy) Award 11,279 11,279 11 Jun 2025 Direct
Abraham Ceesay PCRX Common Stock Award 117.8% 6,163 11,393 11 Jun 2025 Direct
Abraham Ceesay PCRX Stock Option (Right to Buy) Award 11,279 11,279 11 Jun 2025 Direct
Mark Froimson PCRX Common Stock Award 42.6% 6,163 20,636 11 Jun 2025 Direct
Mark Froimson PCRX Stock Option (Right to Buy) Award 11,279 11,279 11 Jun 2025 Direct
Marcelo Bigal PCRX Common Stock Award 60.8% 6,163 16,305 11 Jun 2025 Direct
Marcelo Bigal PCRX Stock Option (Right to Buy) Award 11,279 11,279 11 Jun 2025 Direct
Michael J. Yang PCRX Common Stock Award 85.2% 6,163 13,393 11 Jun 2025 Direct
Michael J. Yang PCRX Stock Option (Right to Buy) Award 11,279 11,279 11 Jun 2025 Direct
Christopher Christie PCRX Common Stock Award 58.8% 6,163 16,654 11 Jun 2025 Direct
Christopher Christie PCRX Stock Option (Right to Buy) Award 11,279 11,279 11 Jun 2025 Direct
Alethia Young PCRX Common Stock Award 117.8% 6,163 11,393 11 Jun 2025 Direct
Alethia Young PCRX Stock Option (Right to Buy) Award 11,279 11,279 11 Jun 2025 Direct
Laura Brege PCRX Common Stock Award 35.1% 6,163 23,715 11 Jun 2025 Direct
Laura Brege PCRX Stock Option (Right to Buy) Award 11,279 11,279 11 Jun 2025 Direct
Lauren Riker PCRX Common Stock Sale -8.56% $146,208 $26.21 -5,578 59,564 04 Jun 2025 Direct
Kristen Williams PCRX Common Stock Sale -8.17% $377,226 $26.24 -14,376 161,574 04 Jun 2025 Direct
Lauren Riker PCRX Common Stock Tax liability -4.92% -3,374 65,142 03 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.